Veterinary Medicines

SERUM TRIVALENT EQUIN

Authorised
  • Pasteurella multocida, Serotype D, immunoserum
  • Immunoglobulins against Escherichia coli O8, Equine
  • Immunoglobulins against Salmonella dublin, type H, Equine
  • Immunoglobulins against Salmonella typhimurium, type H, Equine
  • Immunoglobulins against Escherichia coli O9, Equine
  • Immunoglobulins against Salmonella dublin, type O, Equine
  • Immunoglobulins against Salmonella typhimurium, type O, Equine
  • Immunoglobulins against Escherichia coli O15, Equine
  • Immunoglobulins against Escherichia coli O78, Equine
  • Immunoglobulins against Escherichia coli O101, Equine
  • Immunoglobulins against Escherichia coli O117, Equine
  • Pasteurella multocida, Serotype A, immunoserum
Download as PDF

Product identification

Medicine name:
SERUM TRIVALENT EQUIN
Active substance:
  • Pasteurella multocida, Serotype D, immunoserum
  • Immunoglobulins against Escherichia coli O8, Equine
  • Immunoglobulins against Salmonella dublin, type H, Equine
  • Immunoglobulins against Salmonella typhimurium, type H, Equine
  • Immunoglobulins against Escherichia coli O9, Equine
  • Immunoglobulins against Salmonella dublin, type O, Equine
  • Immunoglobulins against Salmonella typhimurium, type O, Equine
  • Immunoglobulins against Escherichia coli O15, Equine
  • Immunoglobulins against Escherichia coli O78, Equine
  • Immunoglobulins against Escherichia coli O101, Equine
  • Immunoglobulins against Escherichia coli O117, Equine
  • Pasteurella multocida, Serotype A, immunoserum
Target species:
  • Equid
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Pasteurella multocida, Serotype D, immunoserum
    1.00
    log10 enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O8, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella dublin, type H, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella typhimurium, type H, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O9, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella dublin, type O, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella typhimurium, type O, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O15, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O78, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O101, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O117, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Pasteurella multocida, Serotype A, immunoserum
    1.00
    log10 enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Equid
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AM
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/3469350 4/1982
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."